Hemodialysis with new cuprophane membranes upregulates expression of granulocyte adhesion molecules and activates 5-lipoxygenase as reflected by the enhanced generation of leukotriene B4 (LTB4). We assessed the role of 5-lipoxygenase activity in hemodialysis-induced upregulation of the granulocyte adhesion molecules, CD lib and CD 18, and granulocyte adhesion to human umbilical vein endothelial cells in an ex vivo dialysis model. 5-Lipoxygenase was effectively inhibited by preincubation of human whole blood with the speciñc inhibitor, BAY XI00 5. Dialysis with new cuprophane but not with new acrylonitrile membranes significantly upregulated expression of CD1 lb and CD 18 by 6-fold and 4-fold, respectively. Inhibition of 5-lipoxygenase did not affect the expression of CD1 lb and CD 18 during dialysis with either of the two membranes. In contrast to the enhanced expression of CD1 lb and CD 18, adhesion of granulocytes to human umbilical vein endothelial cells did not increase during dialysis, nor was it affected by BAY XI005. These data indicate that ex vivo dialysis with cuprophane membranes upregulates expression of CD1 lb and CD 18 on granulocytes independent of the activation of 5-lipoxygenase.
Synthesis of an Insulin A‐Chain Fragment A14–21 with the Diphenylmethyl Protecting Group for Cysteine
The synthesis of the C‐terminal octapeptide of the insulin A‐chain, N‐2‐[biphenylyl‐(4)]‐propyl‐(2)‐oxycarbonyl‐O‐tert.‐butyl‐L‐tyrosyl‐L‐glutaminyl‐L‐leucyl‐γ‐tert.‐butyl‐L‐glutamyl‐L‐asparaginyl‐O‐tert.‐butyl‐L‐tyrosyl‐S‐diphenylmethyl‐L‐cysteinyl‐L‐asparagine‐tert.‐butylester, by conventional fragment condensations is described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.